Francisco José Ortuño Giner
|
Ortuño FJ, Castilla C, Moreno MJ, del Mar Osma M, Gonzalez M, Vicente V. Erythrophagocytosis in de novo-philadelphia-positive acute leukemia of ambiguous lineage. Haematologica. 2006 Aug;91(8 Suppl):ECR43. PubMed PMID: 16923527.
AÑO: 2006; IF: 5.032
|
16923527
|
del Mar Osma M, Gonzalez-Billalabeitia E, Ortuño FJ, Jerez A, Ayala F, Vicente V. Transient massive peripheral blood blastosis in patient with renal clear-cell carcinoma after treatment with high-dose recombinant interleuklin-2. Lancet Oncol. 2007 Mar;8(3):275-6. PubMed PMID: 17329199.
AÑO: 2007; IF: 12.247
|
|
Fuster JL, Bermúdez M, Galera A, Llinares ME, Calle D, Ortuño FJ. Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica. 2007 Dec;92(12):1723-4. PubMed PMID: 18056006.
AÑO: 2007; IF: 5.516
|
|
Martinez-Redondo C, Ortuño FJ, Lozano ML, Jerez A, Del Mar Osma M, Giraldo P, Vicente V. IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report. J Inherit Metab Dis. 2009 Jun 27. [Epub ahead of print] PubMed PMID: 19562501.
AÑO: 2009; IF: 3.598
|
|
Jerez A, Ortuño FJ, Osma Mdel M, Español I, González AD, Roldán V, de Arriba F, Vicente V. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance. Ann Med. 2009;41(7):547-58. doi: 10.1080/07853890903111000. PubMed PMID: 19634064.
AÑO: 2009; IF: 4.246
|
Instituto de Investigación Sanitaria Acreditado
Fondo Social Europeo "El FSE Invierte en tu futuro"
Sello de Calidad Europeo "HR Excellence in Research"
Dirección
Pabellón Docente del Hospital
Clínico Universitario Virgen de la Arrixaca - 3ª Planta
C/ Campo 12, 30120 - El Palmar - Murcia, España
Teléfonos
+34 968359767
+34 968381298
El Instituto
Investigación
Actualidad
Convocatorias